Caspofungin acetate

Paul A. Pham, Pharm.D., John G. Bartlett, M.D.

Caspofungin acetate is a topic covered in the Johns Hopkins ABX Guide.

To view the entire topic, please log in or purchase a subscription.

Official website of the Johns Hopkins Antibiotic (ABX), HIV, Diabetes, and Psychiatry Guides, powered by Unbound Medicine. Johns Hopkins Guide App for iOS, iPhone, iPad, and Android included. Explore these free sample topics:

Monkeypox

Coronavirus COVID-19 (SARS-CoV-2)

Suicide Risk in the COVID-19 Pandemic

Moderna COVID-19 Vaccine

BNT162b2 COVID-19 Vaccine (BioNTech/Pfizer)

Managing Stress and Coping with COVID-19

Johnson & Johnson COVID-19 Vaccine

-- The first section of this topic is shown below --

INDICATIONS

FDA

Treatment of invasive aspergillosis in patients who are refractory to or intolerant of other anti-fungal therapy.
- Candidemia and the following Candida infections: intra-abdominal abscesses, peritonitis and pleural space infections.
- Note: not well studied in endocarditis, osteomyelitis, and meningitis (low CNS penetration) due to Candida.
Esophageal candidiasis (authors’ opinion: would reserve caspofungin for azole-resistant cases).
Empiric treatment of presumed fungal infections in febrile neutropenic patients.

-- To view the remaining sections of this topic, please log in or purchase a subscription --

INDICATIONS

FDA

Treatment of invasive aspergillosis in patients who are refractory to or intolerant of other anti-fungal therapy.
- Candidemia and the following Candida infections: intra-abdominal abscesses, peritonitis and pleural space infections.
- Note: not well studied in endocarditis, osteomyelitis, and meningitis (low CNS penetration) due to Candida.
Esophageal candidiasis (authors’ opinion: would reserve caspofungin for azole-resistant cases).
Empiric treatment of presumed fungal infections in febrile neutropenic patients.

There's more to see -- the rest of this topic is available only to subscribers.